Read More Pharma Industry News What REYOBIQ’s Phase 1 data means for the future of CNS-directed radiopharmaceutical platforms What does REYOBIQ’s Phase 1 data reveal about the future of CNS-targeted radiopharmaceuticals? Explore the broader neuro-oncology implications. bySoujanya RaviMay 10, 2026